FIC Capital’s Pfizer PFE Stock Holding History

FIC Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-41,275	Closed	-$1.27M	–	123
2016 Q4	$1.27M	Sell	41,275 -14,131	-26%	-$431K	0.64%	51
2016 Q3	$1.78M	Sell	55,406 -1,610	-3%	-$53.8K	0.8%	42
2016 Q2	$1.91M	Sell	57,016 -332	-0.6%	-$10.6K	0.9%	36
2016 Q1	$1.61M	Buy	57,348 +8,037	+16%	+$230K	0.78%	41
2015 Q4	$1.51M	Buy	49,311 +563	+1%	+$17.7K	0.67%	49
2015 Q3	$1.45M	Sell	48,748 -527	-1%	-$16.9K	0.68%	47
2015 Q2	$1.57M	Sell	49,275 -974	-2%	-$31.7K	0.62%	50
2015 Q1	$1.66M	Hold	50,249	–	–	0.63%	53
2014 Q4	$1.49M	Hold	50,249	–	–	0.57%	56
2014 Q3	$1.41M	Sell	50,249 -1,062	-2%	-$29.8K	0.56%	60
2014 Q2	$1.45M	Sell	51,311 -469	-0.9%	-$13.4K	0.56%	59
2014 Q1	$1.58M	Sell	51,780 -553	-1%	-$16.5K	0.64%	57
2013 Q4	$1.52M	Sell	52,333 -1,057	-2%	-$30.8K	0.68%	49
2013 Q3	$1.46M	Buy	53,390 +25,870	+94%	+$704K	0.74%	48
2013 Q2	$731K	Buy	+27,520	New	+$760K	0.47%	69

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

FIC Capital's PFE Position: Q1 2017 in Review

FIC Capital sold out of Pfizer (PFE) in Q1 2017, closing a stake of 41,275 shares — an estimated $1.27M sold.

FIC Capital first reported a position in PFE in Q2 2013 and held it in 15 quarters. The position peaked at $1.91M in Q2 2016. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

FIC Capital reported no remaining Pfizer position as of Q1 2017 after selling out during the quarter.
FIC Capital sold 41,275 Pfizer shares in Q1 2017, an estimated $1.27M.
FIC Capital first reported a position in Pfizer in Q2 2013 and held it in 15 quarters.
FIC Capital's Pfizer position peaked at $1.91M in Q2 2016.
2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on FIC Capital's 13F filing for Q1 2017, filed 12 May 2017.